These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26802722)

  • 41. The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review.
    Muangchan C; ; Baron M; Pope J
    J Rheumatol; 2013 Sep; 40(9):1545-56. PubMed ID: 23858045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Scleroderma and related disorders: therapeutic aspects.
    Denton CP; Black CM
    Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):17-35. PubMed ID: 10882212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic sclerosis: an update.
    Varga J
    Bull NYU Hosp Jt Dis; 2008; 66(3):198-202. PubMed ID: 18937632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Systemic sclerosis--pathogenesis, clinical manifestations and treatment].
    Radić M; Kaliterna DM; Fabijanić D; Radić J
    Lijec Vjesn; 2010; 132(5-6):162-8. PubMed ID: 20677623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Systemic sclerosis].
    Peltomaa R; Pettersson T; Tuompo R; Luosujärvi R
    Duodecim; 2013; 129(19):1981-91. PubMed ID: 24218729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
    In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
    Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
    Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Systemic sclerosis-clinical picture, diagnosis, and treatment].
    Becker MO; Distler O; Maurer B
    Hautarzt; 2019 Sep; 70(9):723-741. PubMed ID: 31384958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.
    Jaeger VK; Wirz EG; Allanore Y; Rossbach P; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Balbir Gurman A; Tikly M; Vettori S; Damjanov N; Müller-Ladner U; Distler JH; Li M; Walker UA;
    PLoS One; 2016; 11(10):e0163894. PubMed ID: 27706206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.
    Takahashi T; Asano Y; Noda S; Aozasa N; Akamata K; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Br J Dermatol; 2015 Sep; 173(3):681-9. PubMed ID: 25781362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis.
    Michalska-Jakubus M; Kowal-Bielecka O; Smith V; Cutolo M; Krasowska D
    Microvasc Res; 2017 Mar; 110():24-31. PubMed ID: 27889559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Systemic sclerosis : What is currently available for treatment?].
    Becker MO
    Internist (Berl); 2016 Dec; 57(12):1155-1163. PubMed ID: 27796473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Renal and extra-renal involvement in sclerodermia].
    Visconti L; Atteritano M; Buemi M; Santoro D
    G Ital Nefrol; 2014; 31(5):. PubMed ID: 25315720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement.
    Nordenbaek C; Johansen JS; Halberg P; Wiik A; Garbarsch C; Ullman S; Price PA; Jacobsen S
    Scand J Rheumatol; 2005; 34(4):293-7. PubMed ID: 16195162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic sclerosis sine scleroderma.
    Kucharz EJ; Kopeć-Mędrek M
    Adv Clin Exp Med; 2017 Aug; 26(5):875-880. PubMed ID: 29068586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.